Exerkine Corporation is a biotech-pharmaceutical company that is developing highly effective new therapies to treat a variety of genetic and aging-associated diseases based on recent developments in the understanding of exercise physiology. Our passion for health and fitness are driving efforts to discover, develop and commercialize therapies that will ameliorate or cure many acquired or genetic diseases. Exerkine’s research and development platform is driving innovation in nutrapharmaceutical consumer products as well as in cytokine-based therapies. Doing business as Stay Above Nutrition, our focus is to commercialize products that are Built and Backed by Science.
There is no investment information
No recent news or press coverage available for Exerkine Corporation.
We care about your data, and we'd love to use cookies make your experience better.
